• Press Releases

SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for T...

Read Press Release from
October 23, 2018

SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of ...

Read Press Release from
October 16, 2018

SetPoint Medical Appoints Murthy Simhambhatla as President and Chief Executive Officer

Read Press Release from
August 24, 2018

SetPoint Medical Reports Positive Long-term Results from its Clinical Study of Bioelectronic Medicine to T...

Read Press Release from
June 19, 2018

SetPoint Medical Presents Positive Data from its Clinical Study of Bioelectronic Medicine for Treatment of...

Read Press Release from
June 11, 2018

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

Read Press Release from
May 21, 2018

SetPoint Medical Announces U.S. Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arth...

Read Press Release from
March 26, 2018

SetPoint Medical Employees Dedicate Their Day to Hope Gardens

Read Press Release from
February 15, 2018

SetPoint Medical Reports Positive Results from Two Bioelectronic Medicine Studies at North American Neuromo...

Read Press Release from
January 14, 2018

FDA Approves Investigational Device Exemption for SetPoint Bioelectronic Therapy Clinical Study in Rheumato...

Read Press Release from
December 11, 2017

SetPoint Medical Presents Early Data Showing Bioelectronic Medicine Accelerates Remyelination in Animal Mod...

Read Press Release from
October 30, 2017

SetPoint Secures $30 Million Series D Equity Financing

Read Press Release from
August 28, 2017